ION-455

N/A

Report date: 2024/04/01 17:55:15
NME

Base Information

Drug NameION-455
Drug Alias NameAZD-7503AZD7503ION455ION-455
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of Action17-beta-hydroxysteroid dehydrogenase 13 Expression Inhibitors
Targets17-beta-hydroxysteroid dehydrogenase 13
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsFatty Liver

Other Information

ATC CodeN/A
Related LinksN/A